Health·The Guardian·5d agoAustralia
PMOS Patients Push for PBS Subsidy of GLP-1 Drugs
Advocates seek equitable access to weight-loss medications
Neutral1 min readImportance
AI Summary
Australian advocates urge PBS subsidy of GLP-1 drugs for polyendocrine metabolic ovarian syndrome, which affects one in eight women, as patients are prescribed the medications off-label without TGA approval.
Keywords
GLP-1 drugsPMOSPBS subsidywomen's healthAustralia
